ZimVie (NAS:ZIMV) EBIT per Share

: $-3.51 (TTM As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

ZimVie's EBIT per Share for the three months ended in Dec. 2022 was $-0.83. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2022 was $-3.51.

During the past 3 years, the average EBIT per Share Growth Rate was -33.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for ZimVie's EBIT per Share or its related term are showing as below:

ZIMV' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -33.7 Med: -33.4 Max: -33.1
Current: -33.7

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of ZimVie was -33.10% per year. The lowest was -33.70% per year. And the median was -33.40% per year.

ZIMV's 3-Year EBIT Growth Rate is ranked worse than
90.39% of 697 companies
in the Medical Devices & Instruments industry
Industry Median: 8.60 vs ZIMV: -33.70

ZimVie's EBIT for the three months ended in Dec. 2022 was $-21.8 Mil.

ZimVie EBIT per Share Historical Data

The historical data trend for ZimVie's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

-18.17

-1.06

-8.47

-3.87

-3.51

ZimVie Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
EBIT per Share								-2.51	-1.24	-0.82	-0.61	-0.83

ZimVie EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

ZimVie's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-91.64	/	26.083
=	-3.51

ZimVie's EBIT per Share for the quarter that ended in Dec. 2022 is calculated as

	EBIT per Share		(Q: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-21.785	/	26.110
=	-0.83

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.51

ZimVie (NAS:ZIMV) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

ZimVie EBIT per Share Related Terms

Thank you for viewing the detailed overview of ZimVie's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ZimVie (NAS:ZIMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

O23:Germany

Address

10225 Westmoor Drive, Westminster, CO, USA, 80021

Website

https://www.zimvie.com

ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments being the spine products segment and the dental products segment.

Executives

Sally Crawford	director	C/O HOLOGIC, INC., BEDFORD MA 01730
Richard Kuntz	director	MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar	director	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec	director	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King	director	PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Zimmer Biomet Holdings, Inc.	10 percent owner	345 EAST MAIN STREET, WARSAW IN 46580
Rebecca Ann Whitney	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Vafa Jamali	director, officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider	officer: Chief Accounting Officer	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021